Cryopreserved veins in myocardial revascularization: Possible mechanism for their increased failure

Annals of Thoracic Surgery

Volumn 63, Issue 4, 1997, Pages 1063-1069

  Bilfinger, Thomas V ^a   Hartman, Alan R ^a   Liu, Yu ^a   Magazine, Harold I ^a   Stefano, George B ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; ENDOTHELIUM; FEMALE; GRAFT PRESERVATION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MAMMARY ARTERY; PRIORITY JOURNAL; SAPHENOUS VEIN;

AGED; CELL ADHESION; CRYOPRESERVATION; ENDOTHELIUM, VASCULAR; FEMALE; GRANULOCYTES; HUMANS; MALE; MAMMARY ARTERIES; MONOCYTES; MORPHINE; MYOCARDIAL REVASCULARIZATION; NALOXONE; NARCOTIC ANTAGONISTS; NITRIC OXIDE; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; SUPEROXIDE DISMUTASE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 0030996716     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00167-7     Document Type: Article

References (25)

1. Stefano GB, Hartman A, Bilfinger TV, et al. Presence of the m3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J Biol Chem 1995;270: 30290-3.
2. Stefano GB, Digenis A, Spector S, et al. Opiatelike substances in an invertebrate, a novel opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci USA 1993;90:11099-103.
3. Stefano GB, Melchiorri P, Negri L, Hughes TKJ, Scharrer B. (D-Ala2)-Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc Natl Acad Sci USA 1992;89:9316-20.
4. Magazine HI, Bruner CA, Andersen TT, Malik AB. Vascular contractile potency of endothelin-1 is increased in the presence of macrophages or monocytes. Am J Physiol 1994;266: H1620-5.
5. 2+ in smooth muscle cells from bovine and porcine coronary artery: modulation of sarcoplasmic reticulum function. Br J Pharmacol 1992;105:903-11.
6. Colton CA, Snell J, Chernyshev O, Gilbert DL. Induction of superoxide anion and nitric oxide production in cultured microglia. Ann N Y Acad Sci 1994;738:54-63.
7. DeCaterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-81.
8. Stefano GB, Scharrer B, Smith EM, et al. Opioid and opiate immunoregulatory processes. Crit Rev Immunol (in press).
9. Cardinale GJ, Donnerer J, Finck AD, Kantrowitz JD, Oka K, Spector S. Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sci 1987;40:301-6.
10. Stefano GB, Bilfinger TV, Fricchione GL. The immune-neuro link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry. Prog Neurobiol 1994;42: 475-88.
11. Matsuki O, Robles A, Gibbs S, Bodnar E, Ross DN. Long term performance of 555 aortic homografts in the aortic position. Ann Thorac Surg 1988;46:187-91.
12. Brockbank KGH, McNally RT, Walsh KT. Cryopreserved vein transplantation. J Cardiovasc Surg 1992;7:170-6.
13. Laub GW, Muralidharan S, Clancy R. Cryopreserved allograft veins as alternative coronary artery bypass conduits: early phase results. Ann Thorac Surg 1992;54:826-31.
14. Louagie YA, Legrand-Monsieur A, Lavenne-Pardonge E. Viability of long term cyropreserved human saphenous veins. J Cardiovasc Surg 1990;31:92-100.
15. Ku D, Winn MJ, Grigsby T, Caulied JB. Human coronary vascular smooth muscle and endothelium-dependent responses after storage at -75°C. Cryobiology 1992;29:199-209.
16. Bambang LS, Mazzucotelli JP, Maczar M, Baeujean F, Loisance D. Effects of cryopreservation on the proliferation and anticoagulant activity of human saphenous vein endothelial cells. J Thorac Cardiovasc Surg 1995;110:998-1004.
17. Marshin RS, Edwards WH, Mulherin JL, Edwards WH Jr, Jenkins JM, Hoff SJ. Cryopreserved saphenous vein allografts for below knee lower extremity revascularization. Ann Surg 1994;219:664-72.
18. Campeau L, Enjalbert M, Lesperance J, Vaislic C, Grondin CM, Bourassa MG. Artherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation 1983;68(Suppl 2):1-7.
19. Angelini GD, Passani SE, Breckenridge IM, Newly AC. Native and pressure dependence of damage induced by distention of human saphenous vein coronary artery bypass grafts. Cardiovasc Res 1987;21:902-7.
20. Ramos JR, Berger K, Mansfield PB, Sauvage LR. Histology and endothelial changes of distended and nondistended veins. Ann Surg 1976;183:205-8.
21. Spray TL, Roberts WC. Changes in saphenous veins used for coronary artery bypass grafts. Am Heart J 1977;94:500-16.
22. Rusch NJ, Woodridge TA, Kulig CC. Reactivity of human saphenous veins at atrial perfusion pressures. J Thorac Cardiovasc Surg 1995;110:1005-12.
23. Rinder C, Titch J. Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell response. J Cardiovasc Pharmacol 1996;27:506-12.
24. Engelman DT, Wakanabe M, Engelman RM. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg 1995;110:1047-53.
25. Wanna FS, Obayashi DY, Young JN, DeCampty WM. Simultaneous manipulation of the nitric oxide and prostanoid pathways reduces myocardial reperfusion injury. J Thorac Cardiovasc Surg 1995;110:1054-62.